Clinical Trial Update: Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 randomized study evaluating the cardiovascular effects of SGLT2 inhibitors in patients undergoing hemodialysis, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Maximo Agustin Schiavone | Conditions: Chronic Kidney Disease Requiring Hemodialysis | Phase 2 | Status: RECRUITING